News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
286,286 Results
Type
Article (16005)
Company Profile (123)
Press Release (270158)
Section
Business (93182)
Career Advice (490)
Deals (15987)
Drug Delivery (67)
Drug Development (40458)
Employer Resources (58)
FDA (6873)
Job Trends (6815)
News (160308)
Policy (15143)
Tag
Academia (684)
Alliances (24857)
Alzheimer's disease (461)
Approvals (6870)
Artificial intelligence (70)
Bankruptcy (145)
Best Places to Work (4979)
Biotechnology (55)
Breast cancer (63)
Cancer (463)
Career advice (430)
Cell therapy (86)
Clinical research (33502)
Collaboration (206)
Compensation (82)
COVID-19 (888)
C-suite (60)
Data (528)
Diabetes (71)
Diagnostics (1423)
Drug pricing (61)
Earnings (32880)
Employer resources (50)
Events (40988)
Executive appointments (208)
FDA (7110)
Funding (145)
Gene therapy (80)
GLP-1 (310)
Government (1517)
Healthcare (4640)
Infectious disease (910)
Inflammatory bowel disease (57)
Interviews (63)
IPO (6235)
Job creations (2099)
Job search strategy (394)
Layoffs (173)
Legal (3557)
Lung cancer (67)
Manufacturing (108)
Medical device (1520)
Medtech (1522)
Mergers & acquisitions (9817)
Metabolic disorders (198)
Neuroscience (599)
NextGen Class of 2024 (2000)
Non-profit (1763)
Northern California (586)
Obesity (114)
Opinion (126)
Patents (64)
People (30131)
Pharmaceutical (69)
Phase I (8986)
Phase II (14301)
Phase III (12494)
Pipeline (213)
Policy (49)
Postmarket research (1495)
Preclinical (3641)
Radiopharmaceuticals (116)
Rare diseases (133)
Real estate (2738)
Regulatory (10684)
Research institute (960)
Resumes & cover letters (58)
Southern California (556)
Startups (1758)
United States (5405)
Vaccines (144)
Weight loss (80)
Date
Today (39)
Last 7 days (269)
Last 30 days (1166)
Last 365 days (14293)
2024 (13891)
2023 (16131)
2022 (21905)
2021 (22695)
2020 (21388)
2019 (17189)
2018 (13408)
2017 (15061)
2016 (14456)
2015 (16924)
2014 (13373)
2013 (11314)
2012 (12005)
2011 (12554)
2010 (11462)
Location
Africa (349)
Asia (20935)
Australia (2825)
California (1323)
Canada (695)
China (137)
Colorado (49)
Connecticut (52)
Europe (41724)
Florida (189)
Illinois (135)
Indiana (92)
Japan (51)
Kansas (58)
Maryland (222)
Massachusetts (1109)
Minnesota (71)
New Jersey (514)
New York (367)
North Carolina (347)
Northern California (586)
Ohio (53)
Pennsylvania (341)
South America (529)
Southern California (556)
Texas (182)
Virginia (48)
Washington State (86)
286,286 Results for "cure pharmaceutical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Cure Rare Disease Expands Leadership Team and Board of Directors to Advance Mission
Cure Rare Disease, a clinical-stage nonprofit biotechnology organization, announces the addition of a Chief Advancement Officer to its leadership team and welcomes three new members to its board of directors.
June 17, 2024
·
3 min read
Biotech Beach
ACTG Announces Launch of its First HIV Cure Clinical Trial in Africa
ACTG, a global clinical trials network focused on HIV and other infectious diseases, announced the opening of the PAUSE study, the first ACTG HIV cure clinical trial to take place on the African continent.
June 13, 2024
·
5 min read
Press Releases
Code Pharma’s Gammora® Demonstrates Highly Favorable Outcomes Toward a Potential Cure for HIV
November 13, 2024
·
2 min read
Press Releases
Arbutus’ Imdusiran Achieves Functional Cure in cHBV Patients when Combined with a Short Course of Interferon
November 18, 2024
·
10 min read
Lone Star Bio
How CNS Pharmaceuticals Is Taking A Different Approach To Find A Treatment For Glioblastoma, A Cancer With A Poor Prognosis And No Cure
How CNS Pharmaceuticals Is Taking A Different Approach To Find A Treatment For Glioblastoma, A Cancer With A Poor Prognosis And No Cure.
December 6, 2023
·
4 min read
Lone Star Bio
Texas Company’s Mission to Cure Macular Degeneration Blindness
Mesogen Inc. out of The Woodlands, Texas, has developed a transplantable Retinal Pigmented Epithelium patch to cure Macular Degeneration Blindness using autologous bone marrow-derived stem cells that carry no teratoma tumor risk and requires no immunosuppression.
April 30, 2024
·
1 min read
Leading Pharmaceutical Company Selects Kinaxis to Cure Supply Chain Headaches
Kinaxis® Inc., a global leader in end-to-end supply chain orchestration, announced that Servier, a global independent pharmaceutical group, has selected Kinaxis to help revolutionize its supply chain planning capabilities with a view to accelerating time to market for its portfolio of life-saving drugs.
May 21, 2024
·
4 min read
Press Releases
8 Years Survival with Complete Cure for a Patient with Advanced Liver Cancer Being Treated with Can-Fite’s Namodenoson Drug
December 5, 2024
·
6 min read
Pharm Country
Mitsubishi Tanabe Pharma America Presents New Results of RADICAVA® (edaravone) for People Living with ALS at the European Network to Cure ALS (ENCALS) Meeting 2024
Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced results from two studies of RADICAVA® (edaravone) for amyotrophic lateral sclerosis (ALS) at the European Network to Cure Amyotrophic Lateral Sclerosis (ENCALS) 2024 meeting.
June 17, 2024
·
8 min read
Business
Berlin Cures Expands Research Capabilities and Scientific Expertise with New Advisory Board
Berlin Cures, a biotechnology company in Phase II clinical trial for a treatment against Long COVID, appoints six distinguished scientists to a new advisory board.
April 3, 2024
·
3 min read
1 of 28,629
Next
